{"filing":{"accession_number":"0001493152-26-041055","cik":"0001725430","ticker":"INBS","company_name":"INTELLIGENT BIO SOLUTIONS INC.","form":"8-K","filing_date":"2026-09-01","report_date":"2026-09-01","primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1725430/000149315226041055/form8-k.htm"},"events":[{"id":31070,"run_id":28492,"accession_number":"0001493152-26-041055","anchor_item_number":null,"event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"summary":"The filing discloses results of a Method Comparison Study for the company's Intelligent Fingerprinting Drug Screening System, showing above 98% accuracy and improved sensitivity (94.6% vs. prior 82%), with the company announcing an accelerated 510(k) FDA submission timeline for September 2026. This is a material operational/regulatory milestone—the study results directly support the company's path to FDA clearance and U.S. market entry, a critical business objective. While not fitting a specific named category, this is clearly an operational/strategic event material to investors assessing the company's regulatory progress and commercialization prospects.","company_name":"INTELLIGENT BIO SOLUTIONS INC.","ticker":"INBS","filing_date":"2026-09-01","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":33862,"accession_number":"0001493152-26-041055","item_number":null,"item_title":null,"event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"The filing discloses results of a Method Comparison Study for the company's Intelligent Fingerprinting Drug Screening System, showing above 98% accuracy and improved sensitivity (94.6% vs. prior 82%), with the company announcing an accelerated 510(k) FDA submission timeline for September 2026. This is a material operational/regulatory milestone—the study results directly support the company's path to FDA clearance and U.S. market entry, a critical business objective. While not fitting a specific named category, this is clearly an operational/strategic event material to investors assessing the company's regulatory progress and commercialization prospects.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-01T21:12:50.491333+00:00","company_name":"INTELLIGENT BIO SOLUTIONS INC.","ticker":"INBS","filing_date":"2026-09-01"}]}